Zimmer Biomet Holdings, Inc. (ZBH) held by 189 SEC 13F Filers

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) recovered 24.34% of its value since hitting low of $104.28. The recent move of 2.75% gain helped the stock to close at $129.66 when trading ended on September 13, 2018. At recent session, the prices were hovering between $126.07 and $129.92. This company shares are 5.19% off its target price of $136.39 and the current market capitalization stands at $26.34B. The recent change has given its price a 7.35% lead over SMA 50 and 0.25% lead over its 52-week high. The stock witnessed 5.95% gains, 12.87% gains and 11.85% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found ZBH’s volatility during a week at 1.79% and during a month it has been found around 1.54%.

Zimmer Biomet Holdings, Inc. (ZBH) Top Holders

Institutional investors currently hold around $22.82 billion or 89.2% in ZBH stock. Look at its top three institutional owners. Blackrock Inc. owns $1.93 billion in Zimmer Biomet Holdings, Inc., which represents roughly 7.34% of the company’s market cap and approximately 8.48% of the institutional ownership. Similar statistics are true for the second largest owner, Massachusetts Financial Services Co /Ma/, which owns 14,526,176 shares of the stock are valued at $1.83 billion. The third largest holder is Vanguard Group Inc, which currently holds $1.8 billion worth of this stock and that ownership represents nearly 6.84% of its market capitalization.

Zimmer Biomet Holdings, Inc. 13F Filings

At the end of June reporting period, 352 institutional holders increased their position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by some 12,226,219 shares, 389 decreased positions by 13,816,400 and 189 held positions by 155,000,000. That puts total institutional holdings at 181,000,000 shares, according to SEC filings. The stock grabbed 62 new institutional investments totaling 2,671,920 shares while 65 institutional investors sold out their entire positions totaling 1,386,971 shares.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Insider Trades

Multiple company employees have indulged in significant insider trading. Zimmer Biomet Holdings, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that President and CEO Hanson Bryan C has acquired 410 shares of Zimmer Biomet Holdings, Inc. (ZBH) in trading session dated Aug. 31, 2018. These shares are worth $50,442 and were traded at $123.03 each. The SEC filing shows that Collins Tony W. performed a sale of 2,778 shares. The VP, Controller and CAO disposed these shares by way of transaction on Jul. 31, 2018. The company’s shares were given away at $125.77 per share worth to an income of some $349,389 on account of Collins Tony W..

Pres., Eur., M. East & Afr., Mazur-Hofsaess Katarzyna, sold 8,765 common shares of Zimmer Biomet Holdings, Inc. (ZBH) in the open market. In a transaction dated May. 22, 2018, the shares were put up for sale at an average price of $114, raking in a sum of $995,792. After this sale, 16,682 common shares of ZBH are directly owned by the insider, with total stake valued at $2,162,988.

In the transaction dated Apr. 30, 2018, the great number of shares disposed came courtesy the VP, Controller and CAO; Collins Tony W. disposed a total of 1,330 shares at an average price of $116.73, amounting to approximately $155,251. The insider now directly owns 338 shares worth $43,800.

Zimmer Biomet Holdings, Inc. (ZBH) Analyst Guide

Several analysts have released their opinion on Zimmer Biomet Holdings, Inc. (NYSE:ZBH), with 12 analysts believing it is a strong buy. Whereas 9 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 1 strong sell ratings, collectively assigning a 2 average brokerage recommendation.